In Vivo Detection of Free Radical Generation
自由基产生的体内检测
基本信息
- 批准号:8734091
- 负责人:
- 金额:$ 62.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Animal Disease ModelsAntibodiesBiochemicalBiochemical PathwayBiologicalComplexDetectionDiesel ExhaustDiseaseElectron MicroscopyEndotoxinsExotoxinsFree Radical FormationFree RadicalsGenerationsHumanImmune System DiseasesImmunityIn VitroInfectionInflammationInflammatoryInvestigationLipidsLipopolysaccharidesLiquid substanceLungLung InflammationMediatingMediator of activation proteinMetalsMethodsObesityOrganPathogenesisProductionPseudomonas aeruginosaReactionResearch PrioritySpin TrappingStaphylococcal Enterotoxin BSteatohepatitisSulfitesSuperantigensTechniquesTestingTissuesToxic effectWorkadductallergic responsedisorder riskenvironmental agentin vivonovelparticlepathogenresponsetoxic metal
项目摘要
We have set research priorities to focus on free radical generation in animal models of disease and toxicity for which there is a strong indication of an environmental component. The ways in which environmental agents increase disease risks and toxicity are still poorly understood. In the past our work has been concentrated on the in vivo formation and detection of free radicals from toxic metals and organic compounds and extended into investigations of free radical formation during inflammation caused by lipopolysaccharide itself and in combination with diesel exhaust particles. It is now continued into studies of environmental exotoxins and pathogens with the aim of understanding the basic free radical mechanisms involved in distinctive organ infections, immune disease, and obesity.
In vivo spin trapping has been the most successful method for the detection of highly reactive free radical molecules in vivo. The group continued to use spin trapping to solve in vitro biochemical and in vivo toxicological disease problems by using two major approaches for spin trapping, with either ESR detection or antibody recognition and MS identification of the trapped radical.
By the use of in vivo spin-trapping methods, these studies test the hypotheses that: 1) free radicals are causative molecules in the complex pathogenesis of lung infections, obesity and allergic response; and 2) specific biochemical pathways are involved in triggering generation of free radicals that may act as mediators and/or modulators of inflammatory reactions associated with human immunity and disease response. Free radical generation in vivo caused by the bacterial pathogen Pseudomonas aeruginosa, superantigen staphylococcal enterotoxin B, the endotoxin LPS, obesity, CCl4, and sulfites has been shown in specific states of lung inflammation, steatohepatitis, and allergic response.
我们已经确定了研究重点,重点是疾病和毒性的动物模型中的自由基生成,其中有强烈的环境成分的迹象。 环境因素增加疾病风险和毒性的方式仍然知之甚少。在过去,我们的工作一直集中在体内形成和检测的自由基从有毒金属和有机化合物,并扩展到自由基形成的调查过程中引起的炎症脂多糖本身,并结合柴油机尾气颗粒。 它现在继续研究环境外毒素和病原体,目的是了解参与独特器官感染,免疫疾病和肥胖症的基本自由基机制。
在体内自旋捕获已成为最成功的方法,用于检测高活性的自由基分子在体内。该小组继续使用自旋捕获来解决体外生物化学和体内毒理学疾病问题,通过使用两种主要的自旋捕获方法,ESR检测或抗体识别和MS鉴定捕获的自由基。
通过使用体内自旋捕获方法,这些研究测试了以下假设:1)自由基是肺部感染、肥胖和过敏反应的复杂发病机制中的致病分子;以及2)特定的生化途径参与触发自由基的产生,所述自由基可以充当与人体免疫和疾病反应相关的炎症反应的介质和/或调节剂。由细菌病原体铜绿假单胞菌、超抗原葡萄球菌肠毒素B、内毒素LPS、肥胖症、CCl 4和亚硫酸盐引起的体内自由基产生已在肺部炎症、脂肪性肝炎和过敏反应的特定状态中显示。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD P MASON其他文献
RONALD P MASON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD P MASON', 18)}}的其他基金
CHARACTERIZATION OF RAT HEMOGLOBIN THIYL RADICALS BY W BAND
通过 W 波段表征大鼠血红蛋白硫酰基自由基
- 批准号:
6120646 - 财政年份:1998
- 资助金额:
$ 62.66万 - 项目类别:
CHARACTERIZATION OF RAT HEMOGLOBIN THIYL RADICALS BY W BAND
通过 W 波段表征大鼠血红蛋白硫酰基自由基
- 批准号:
6251759 - 财政年份:1997
- 资助金额:
$ 62.66万 - 项目类别:
DETECT AND CHARACTERIZE FREE RADICAL METABOLITES OF HYDRAZINE BASED DRUGS
检测并表征肼基药物的自由基代谢物
- 批准号:
6254253 - 财政年份:1997
- 资助金额:
$ 62.66万 - 项目类别:
NITRIC OXIDE AND THE METABOLISM OF TOXIC CHEMICALS AND DRUGS
一氧化氮与有毒化学品和药物的代谢
- 批准号:
6106716 - 财政年份:
- 资助金额:
$ 62.66万 - 项目类别:
Role Of Mammalian Peroxidases In Oxidative Stress
哺乳动物过氧化物酶在氧化应激中的作用
- 批准号:
6535046 - 财政年份:
- 资助金额:
$ 62.66万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 62.66万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 62.66万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 62.66万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 62.66万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 62.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 62.66万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 62.66万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 62.66万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 62.66万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 62.66万 - 项目类别: